Alliqua BioMedical Company Profile (NASDAQ:ALQA)

About Alliqua BioMedical

Alliqua BioMedical logoAlliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company's businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. The Company utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into water to create a feed mix. The Company's commercial wound care portfolio consists of over four product categories, such as Human Biologics; Antimicrobial Protection; Exudate Management and Contract Manufacturing. Human Biologics include BIOVANCE and Extracellular Matrix (ECM). Under Antimicrobial Protection, the Company offers TheraBond 3D Antimicrobial Barrier Systems and SilverSeal.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ALQA
  • CUSIP:
Key Metrics:
  • Previous Close: $0.48
  • 50 Day Moving Average: $0.578
  • 200 Day Moving Average: $0.741
  • 52-Week Range: $0.45 - $1.48
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.72
  • P/E Growth: -0.040
  • Market Cap: $14.36M
  • Outstanding Shares: 29,672,000
  • Beta: 1.15
Profitability:
  • Net Margins: -81.72%
  • Return on Equity: -52.26%
  • Return on Assets: -33.50%
Debt:
  • Current Ratio: 0.91%
  • Quick Ratio: 0.74%
Additional Links:
Companies Related to Alliqua BioMedical:

Analyst Ratings

Consensus Ratings for Alliqua BioMedical (NASDAQ:ALQA) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.88 (494.01% upside)

Analysts' Ratings History for Alliqua BioMedical (NASDAQ:ALQA)
Show:
DateFirmActionRatingPrice TargetDetails
11/8/2016HC WainwrightReiterated RatingBuyView Rating Details
7/10/2016Chardan CapitalReiterated RatingBuyView Rating Details
2/26/2016Northland SecuritiesLower Price TargetOutperform$7.00 -> $3.00View Rating Details
2/26/2016Craig HallumLower Price TargetBuy$3.00View Rating Details
2/24/2016Royal Bank Of CanadaLower Price TargetOutperform$6.00 -> $3.00View Rating Details
6/26/2015Cowen and CompanyInitiated CoverageOutperform$9.00View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for Alliqua BioMedical (NASDAQ:ALQA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/22/2017        
8/9/2016Q216($0.27)$0.05$5.38 million$5.50 millionViewN/AView Earnings Details
5/10/2016Q116($0.25)($0.20)$4.99 million$4.60 millionViewListenView Earnings Details
2/23/2016Q4($0.28)($0.18)$5.30 million$4.80 millionViewListenView Earnings Details
11/5/2015Q315($0.29)($0.25)$5.44 million$5.00 millionViewN/AView Earnings Details
8/6/2015Q215($0.30)($0.27)$2.85 million$3.10 millionViewN/AView Earnings Details
5/14/2015Q115($0.34)($0.21)$2.37 million$2.10 millionViewListenView Earnings Details
2/24/2015Q414($0.31)($0.34)$1.70 millionViewN/AView Earnings Details
10/30/2014Q3 14($0.31)($0.33)ViewN/AView Earnings Details
8/11/2014Q214($0.41)($0.39)$1.04 millionViewN/AView Earnings Details
5/12/2014($0.40)($0.73)ViewN/AView Earnings Details
3/24/2014Q313($0.23)($1.68)$0.40 million$0.47 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alliqua BioMedical (NASDAQ:ALQA)
Current Year EPS Consensus Estimate: $-0.790 EPS
Next Year EPS Consensus Estimate: $-0.670 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.29)($0.28)($0.29)
Q2 20162($0.27)($0.26)($0.27)
Q3 20162($0.26)($0.24)($0.25)
Q4 20162($0.25)($0.23)($0.24)
Q1 20171($0.16)($0.16)($0.16)
Q2 20171($0.15)($0.15)($0.15)
Q3 20171($0.11)($0.11)($0.11)
Q4 20171($0.10)($0.10)($0.10)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Alliqua BioMedical (NASDAQ:ALQA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alliqua BioMedical (NASDAQ:ALQA)
Insider Ownership Percentage: 15.20%
Institutional Ownership Percentage: 29.90%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2015Brian M PosnerCFOBuy5,000$3.04$15,200.00View SEC Filing  
11/6/2015Bradford BartonCOOBuy5,000$2.97$14,850.00View SEC Filing  
11/6/2015David Ian JohnsonCEOBuy8,650$2.92$25,258.00View SEC Filing  
11/6/2015Jerome B ZeldisDirectorBuy14,000$2.91$40,740.00View SEC Filing  
11/6/2015Pellegrino PionatiInsiderBuy10,000$2.95$29,500.00View SEC Filing  
8/10/2015Brian M PosnerCFOBuy2,500$5.02$12,550.00View SEC Filing  
6/8/2015Bradford BartonCOOBuy3,000$5.25$15,750.00View SEC Filing  
5/27/2015David Ian JohnsonCEOBuy10,000$4.65$46,500.00View SEC Filing  
5/20/2015Brian M PosnerCFOBuy2,500$4.34$10,850.00View SEC Filing  
5/4/2015Corp /De/ CelgeneMajor ShareholderBuy659,340$4.55$2,999,997.00View SEC Filing  
9/15/2014Brian M PosnerCFOBuy2,000$4.94$9,880.00View SEC Filing  
5/13/2014Brian M PosnerCFOBuy3,000$6.92$20,760.00View SEC Filing  
4/14/2014Corp /De/ CelgeneMajor ShareholderBuy714,286$7.00$5,000,002.00View SEC Filing  
5/21/2013Kenneth L LondonerDirectorBuy219,500$0.07$15,365.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Alliqua BioMedical (NASDAQ:ALQA)
DateHeadline
News IconAnalysts Peer Into Their Crystal Balls For Alliqua BioMedical, Inc. (NASDAQ:ALQA): Where Is It headed? - Winfield Review (NASDAQ:ALQA)
winfieldreview.com - February 22 at 8:30 PM
News IconAre Analysts Optimistic About Where Alliqua BioMedical, Inc. (NASDAQ:ALQA) is Heading? - Winfield Review (NASDAQ:ALQA)
winfieldreview.com - February 22 at 3:29 PM
News IconBroker Recommendations on These Stocks: Alliqua BioMedical, Inc. (NASDAQ:ALQA) NutriSystem Inc (NASDAQ:NTRI) - The Standard (NASDAQ:ALQA)
6milestandard.com - February 16 at 3:30 PM
investornewswire.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) EPS Target At $-0.16 - Investor Newswire (NASDAQ:ALQA)
www.investornewswire.com - February 14 at 1:57 AM
biz.yahoo.com logoALLIQUA BIOMEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi (NASDAQ:ALQA)
biz.yahoo.com - February 8 at 3:41 PM
News IconEarnings Parade Rolls On, What Are Analysts Saying About Alliqua BioMedical, Inc. (NASDAQ:ALQA)? - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - February 1 at 3:34 PM
realistinvestor.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) EPS Projection At $-0.16 - RealistInvestor.com (NASDAQ:ALQA)
www.realistinvestor.com - February 1 at 3:34 PM
News IconAre These Shares a Bargain: Update on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Prospect Journal (NASDAQ:ALQA)
prospectjournal.com - January 31 at 8:41 PM
News IconBoom or Bust? Is there any value in Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Prospect Journal (NASDAQ:ALQA)
prospectjournal.com - January 31 at 3:39 PM
News IconAlliqua Biomedical Inc (ALQA) Stock Formed Bullish Descending Triangle. What To Expect? (NASDAQ:ALQA)
randolphguide.com - January 31 at 1:49 AM
News IconCould Alliqua Biomedical Inc (ALQA) Decrease Even More? The ... - The Randolph Guide (NASDAQ:ALQA)
randolphguide.com - January 30 at 3:39 PM
realistinvestor.com logoMean Rating Of Alliqua BioMedical, Inc. (NASDAQ:ALQA) At $1 - RealistInvestor.com (NASDAQ:ALQA)
www.realistinvestor.com - January 29 at 8:28 PM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Nelson Research (NASDAQ:ALQA)
nelsonobserver.com - January 29 at 3:26 PM
News IconOff To a Slow Start in The New Year, Stock Looks For a Turnaround: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Aiken Advocate (NASDAQ:ALQA)
aikenadvocate.com - January 28 at 8:31 PM
News IconPrepping for a Big Move? Share Update on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Prospect Journal (NASDAQ:ALQA)
prospectjournal.com - January 27 at 3:36 PM
investornewswire.com logoStrong Sell Recommendations Of Alliqua BioMedical, Inc. (NASDAQ:ALQA) At 0 - Investor Newswire (NASDAQ:ALQA)
www.investornewswire.com - January 25 at 8:34 PM
News IconEarnings in Full Force, Analysts Take Aim at Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - January 25 at 3:33 PM
News IconCCI Focus on Shares of Alliqua Inc. (ALQA) - Sherwood Daily (NASDAQ:ALQA)
sherwooddaily.com - January 24 at 3:49 PM
investornewswire.com logoConsensus Rating Of Alliqua BioMedical, Inc. (NASDAQ:ALQA) At 1 - Investor Newswire (NASDAQ:ALQA)
www.investornewswire.com - January 23 at 3:30 PM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - January 22 at 8:17 AM
News IconTrading Indicator Check on Alliqua Inc. (ALQA) - Sherwood Daily (NASDAQ:ALQA)
sherwooddaily.com - January 20 at 9:03 PM
News IconSharp Decline Puts This Stock at a New Low: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - January 20 at 3:58 PM
News IconShould Farsighted Investors Pay Attention to Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Prospect Journal (NASDAQ:ALQA)
prospectjournal.com - January 19 at 8:51 PM
News IconStock to Watch: Alliqua Inc. (ALQA) - Sherwood Daily (NASDAQ:ALQA)
sherwooddaily.com - January 19 at 3:50 PM
News IconExclusive Technical Analysis: Does Alliqua Biomedical Inc Have Any Gas After Forming This Bearish Wedge Down ... - The Herald Beacon (NASDAQ:ALQA)
heraldbeacon.com - January 19 at 3:50 PM
News IconInvestor Probe: Watching Technicals for Alliqua Inc. (ALQA) - Sherwood Daily (NASDAQ:ALQA)
sherwooddaily.com - January 19 at 3:50 PM
News IconAre There Any Catalysts to Propel Shares of Alliqua BioMedical, Inc ... - Prospect Journal (NASDAQ:ALQA)
prospectjournal.com - January 18 at 9:01 PM
News IconCheap Stock Alert on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Prospect Journal (NASDAQ:ALQA)
prospectjournal.com - January 10 at 3:30 PM
realistinvestor.com logoResearch Analysts Set Alliqua BioMedical, Inc. (NASDAQ:ALQA) Price Target at $2.625 - RealistInvestor.com (NASDAQ:ALQA)
www.realistinvestor.com - January 8 at 3:27 PM
News IconStock Check on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - January 8 at 3:27 PM
News IconInvestor Radar: Focusing in on Shares of Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - January 6 at 1:47 AM
investornewswire.com logoSentiments And Ratings Alert: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Investor Newswire (NASDAQ:ALQA)
www.investornewswire.com - January 4 at 3:35 PM
realistinvestor.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) Is Expected To Post EPS Of $-0.16 - RealistInvestor.com (NASDAQ:ALQA)
www.realistinvestor.com - January 4 at 3:35 PM
capitalcube.com logoETFs with exposure to Alliqua BioMedical, Inc. : January 3, 2017 (NASDAQ:ALQA)
www.capitalcube.com - January 3 at 3:50 PM
News IconInvestor Watch: Narrowing in on Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - January 3 at 7:19 AM
realistinvestor.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) Quarterly EPS At $-0.2 - RealistInvestor.com (NASDAQ:ALQA)
www.realistinvestor.com - December 31 at 8:27 PM
News IconShares in Review: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - December 29 at 8:32 PM
investornewswire.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) Strong Buy Recommendations At 5 - Investor Newswire (NASDAQ:ALQA)
www.investornewswire.com - December 29 at 1:30 AM
realistinvestor.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) EPS Estimaged At $-0.16 - RealistInvestor.com (NASDAQ:ALQA)
www.realistinvestor.com - December 28 at 3:28 PM
News IconTwo Stable Stocks: Alliqua BioMedical, Inc. (NASDAQ:ALQA), HollyFrontier Corporation (NYSE:HFC) - The Newburgh Press (NASDAQ:ALQA)
newburghpress.com - December 28 at 3:28 PM
News IconPlacing This Stock in the Hotbed: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Prospect Journal (NASDAQ:ALQA)
prospectjournal.com - December 28 at 7:49 AM
News IconNumbers in View on Shares of Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - December 28 at 7:49 AM
News IconAlliqua BioMedical Gets FDA Marketing Approval For Ultrasound Wound Care System (NASDAQ:ALQA)
www.guerillastocktrading.com - December 27 at 3:47 PM
realistinvestor.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) Mean Rating At $1 - RealistInvestor.com (NASDAQ:ALQA)
www.realistinvestor.com - December 25 at 6:46 AM
News IconIs This Stock Ready to Rumble: Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Prospect Journal (NASDAQ:ALQA)
prospectjournal.com - December 23 at 3:33 PM
investornewswire.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) Strong Sell Recommendations At 0 - Investor Newswire (NASDAQ:ALQA)
www.investornewswire.com - December 22 at 3:28 PM
investornewswire.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) Strong Sell Recommendations At 0 - Investor Newswire (NASDAQ:ALQA)
www.investornewswire.com - December 22 at 3:28 PM
News IconAlliqua Inc (ALQA) Valuation According To Analysts - UK Market News (NASDAQ:ALQA)
www.ukmarketnews.co.uk - December 21 at 4:31 PM
investornewswire.com logoAlliqua BioMedical, Inc. (NASDAQ:ALQA) Records An Impact Score Of 0 - Investor Newswire (NASDAQ:ALQA)
www.investornewswire.com - December 21 at 4:31 PM
News IconStock Review for Alliqua BioMedical, Inc. (NASDAQ:ALQA) - Wall Street Beacon (NASDAQ:ALQA)
wsbeacon.com - December 20 at 8:42 PM

Social

What is Alliqua BioMedical's stock symbol?

Alliqua BioMedical trades on the NASDAQ under the ticker symbol "ALQA."

Where is Alliqua BioMedical's stock going? Where will Alliqua BioMedical's stock price be in 2017?

5 brokerages have issued 12-month price targets for Alliqua BioMedical's shares. Their predictions range from $2.50 to $3.00. On average, they anticipate Alliqua BioMedical's share price to reach $2.88 in the next year.

When will Alliqua BioMedical announce their earnings?

Alliqua BioMedical is scheduled to release their next quarterly earnings announcement on Wednesday, February, 22nd 2017.

Who owns Alliqua BioMedical stock?

Alliqua BioMedical's stock is owned by many different of retail and institutional investors. Top institutional investors include Perceptive Advisors LLC (6.48%), J. Goldman & Co LP (1.82%) and Renaissance Technologies LLC (1.38%). Company insiders that own Alliqua BioMedical stock include Bradford Barton, Brian M Posner, Corp /De/ Celgene, David Ian Johnson, Jerome B Zeldis and Pellegrino Pionati.

Who bought Alliqua BioMedical stock? Who is buying Alliqua BioMedical stock?

Alliqua BioMedical's stock was purchased by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC and Renaissance Technologies LLC. Company insiders that have bought Alliqua BioMedical stock in the last two years include Bradford Barton, Brian M Posner, Corp /De/ Celgene, David Ian Johnson, Jerome B Zeldis and Pellegrino Pionati.

How do I buy Alliqua BioMedical stock?

Shares of Alliqua BioMedical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Alliqua BioMedical stock cost?

One share of Alliqua BioMedical stock can currently be purchased for approximately $0.48.

Alliqua BioMedical (NASDAQ:ALQA) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Alliqua BioMedical (NASDAQ:ALQA)

Earnings History Chart

Earnings by Quarter for Alliqua BioMedical (NASDAQ:ALQA)

Dividend History Chart

Dividend Payments by Quarter for Alliqua BioMedical (NASDAQ:ALQA)

Last Updated on 2/23/2017 by MarketBeat.com Staff